Alexandra Mountford, | |
3500 Old Washington Rd Ste 101, Waldorf, MD 20602-3205 | |
(301) 885-5020 | |
(240) 419-5217 |
Full Name | Alexandra Mountford |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Pediatrics |
Location | 3500 Old Washington Rd Ste 101, Waldorf, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114676822 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | AC004176 (Maryland) | Secondary |
363LP0200X | Nurse Practitioner - Pediatrics | AC004175 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexandra Mountford, 3500 Old Washington Rd Ste 101, Waldorf, MD 20602-3205 Ph: (301) 885-5020 | Alexandra Mountford, 3500 Old Washington Rd Ste 101, Waldorf, MD 20602-3205 Ph: (301) 885-5020 |
News Archive
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
Patients understanding their medications and taking them as instructed are important parts of improving the care and outcomes of heart attack patients, as well as potentially reducing avoidable readmissions, according to research presented at the ACC Quality Summit in New Orleans.
Various active substances in oral antidiabetic agents are frequently combined in the treatment of diabetes in order to achieve an effective reduction in the blood sugar. A new, very promising approach combines the substances metformin and SGLT2 inhibitors, the latter were just approved in 2012.
Dr. Donald L. Trump, President and CEO of Roswell Park Cancer Institute (RPCI), America's first cancer center, will have his head shaved by a Roswell Park cancer patient on March 3, 2010 to honor the Institute's 26,292 patients, and to encourage others to participate in the "Goin' Bald for Bucks" program.
Shire plc, the global specialty biopharmaceutical company, today announced the results of a study evaluating the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder in adolescents aged 13 to 17 years.
› Verified 3 days ago